相关实验视频
Updated: May 9, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
[急性髓性白血病的新陈代谢和治疗与异酸脱酶1/2突变]
Ludovic Gabellier1, Enzo Bosetta2, Maël Heiblig3
1Service d'hématologie clinique, Centre Hospitalier Universitaire de Montpellier, Montpellier, France - Institut de Génétique Moléculaire de Montpellier, CNRS UMR5535, Université de Montpellier, Montpellier, France.
异酸脱酶 (IDH1和IDH2) 的突变通过产生一种代代谢物驱动急性髓性白血病 (AML). 新的抑制剂显示出希望,但像新陈代谢重编程这样的抵抗机制提供了新的治疗途径.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢途径 代谢途径
背景情况:
- 异酸脱酶 (IDH1和IDH2) 是细胞代谢中的关键酶.
- 在IDH1/IDH2中发生的突变在急性髓性白血病 (AML) 中很常见,并导致代代谢物R-2-基酸盐的产生.
- R-2-基氨酸促进白血病发生和AML复发.
研究的目的:
- 研究IDH1/IDH2突变在AML中的作用.
- 探索针对IDH1/IDH2抑制剂的耐药性机制.
- 确定IDH突变AML的新治疗策略.
主要方法:
- 对AML中的代谢重编程的分析.
- 对IDH1和IDH2抑制剂 (ivosidenib和enasidenib) 的耐药性机制的研究.
主要成果:
- IDH1/IDH2突变是AML病变发生的关键驱动因素.
- 代谢重编程是对IDH抑制剂耐药性的重要机制.
- 了解抵抗机制可以为治疗开辟新的机会.
结论:
- 针对IDH突变AML的向治疗改善了患者的治疗结果.
- 代谢重编程在AML治疗中提出了挑战和机遇.
- 对这些机制的进一步研究可以指导AML的未来治疗开发.
更多相关视频
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
08:36Metabolic Mapping: Quantitative Enzyme Cytochemistry and Histochemistry to Determine the Activity of Dehydrogenases in Cells and Tissues
Published on: May 26, 2018
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
What is Metabolism?
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...